HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution

Offered By: Labroots via YouTube

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!

Explore homologous recombination deficiency (HRD) evaluation and scoring using the OncoScan CNV Assay in this informative webinar presented by Yann Christinat, PhD and Stephan Bartels, PhD. Learn about this whole-genome microarray research solution and its applications in identifying HRD as a genome-wide biomarker in high-grade ovarian and breast cancers. Discover how PARP inhibitors, a cancer therapeutic class, induce synthetic lethality in tumors with high levels of HRD. Gain valuable insights into the latest advancements in cancer research and potential therapeutic approaches during this 1-hour and 4-minute presentation.

Syllabus

HRD Evaluation and Scoring using OncoScan CNV Assay, a whole-genome microarray research solution

Taught by

Labroots

Related Courses

Experimental Genome Science
University of Pennsylvania via Coursera Genes and the Human Condition (From Behavior to Biotechnology)
University of Maryland, College Park via Coursera Introduction to Biology - The Secret of Life
Massachusetts Institute of Technology via edX Drug Discovery
University of California, San Diego via Coursera Human Evolution: Past and Future
University of Wisconsin–Madison via Coursera